Envestnet Asset Management Inc Abb Vie Inc. Transaction History

Envestnet Asset Management Inc

$263 Billion
Q1 2024

A detailed history of Envestnet Asset Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 4,669,727 shares of ABBV stock, worth $801 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

4,669,727

Previous 4,569,981 2.18%

Holding current value

$801 Million

Previous $708 Million 20.07%

% of portfolio

0.32%

Previous 0.3%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $15.9 Million - $18.2 Million	99,746 Added 2.18%	4,669,727 $850 Million
Q4 2023 Feb 13, 2024	BUY	$137.6 - $154.97 $23.8 Million - $26.8 Million	172,672 Added 3.93%	4,569,981 $708 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $151 Million - $175 Million	1,130,638 Added 34.61%	4,397,309 $655 Million
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $15.3 Million - $19 Million	-115,099 Reduced 3.4%	3,266,671 $440 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $5.44 Million - $6.27 Million	-37,630 Reduced 1.1%	3,381,770 $539 Million

Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $1.1 Million - $1.32 Million	7,958 Added 0.23%	3,419,400 $553 Million
Q3 2022 Nov 10, 2022	BUY	$134.21 - $153.93 $13.4 Million - $15.4 Million	99,724 Added 3.01%	3,411,442 $458 Million
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $2.02 Million - $2.56 Million	-14,645 Reduced 0.44%	3,311,718 $507 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $18.5 Million - $23 Million	140,424 Added 4.41%	3,326,363 $539 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $5.93 Million - $7.5 Million	55,168 Added 1.76%	3,185,939 $431 Million
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $18.4 Million - $20.9 Million	172,841 Added 5.84%	3,130,771 $338 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $8.29 Million - $9.23 Million	78,780 Added 2.74%	2,957,930 $333 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $59.2 Million - $65.2 Million	579,176 Added 25.18%	2,879,150 $312 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $2.65 Million - $3.58 Million	32,956 Added 1.45%	2,299,974 $246 Million
Q3 2020 Oct 09, 2020	SELL	$85.91 - $100.83 $265,204 - $311,262	-3,087 Reduced 0.14%	2,267,018 $199 Million
Q2 2020 Jul 08, 2020	BUY	$73.37 - $98.18 $10.9 Million - $14.6 Million	148,701 Added 7.01%	2,270,105 $223 Million
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $22.5 Million - $34 Million	348,115 Added 19.63%	2,121,404 $162 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $35 Million - $43.8 Million	485,004 Added 37.65%	1,773,289 $157 Million
Q3 2019 Oct 17, 2019	BUY	$62.98 - $75.72 $7.99 Million - $9.6 Million	126,826 Added 10.92%	1,288,285 $97.5 Million
Q2 2019 Aug 02, 2019	BUY	$65.7 - $83.98 $468,243 - $598,525	7,127 Added 0.62%	1,161,459 $84.5 Million
Q1 2019 May 10, 2019	BUY	$77.14 - $90.79 $4.39 Million - $5.17 Million	56,969 Added 5.19%	1,154,332 $93 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $83.3 Million - $103 Million	1,069,620 Added 3855.46%	1,097,363 $101 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $14.4 Million - $16 Million	-161,891 Reduced 85.37%	27,743 $2.62 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $61,589 - $72,873	-686 Reduced 0.36%	189,634 $17.6 Million
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $9.25 Million - $12.4 Million	-100,583 Reduced 34.58%	190,320 $18.2 Million
Q4 2017 Feb 20, 2018	SELL	$89.56 - $98.21 $1.27 Million - $1.39 Million	-14,186 Reduced 4.65%	290,903 $28.1 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $7.2 Million - $9.2 Million	-103,064 Reduced 25.25%	305,089 $27.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	408,153	408,153 $29.6 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc Abb Vie Inc. Transaction History